Zobrazeno 1 - 10
of 983
pro vyhledávání: '"Tumor Treating Fields"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1056-1062 (2024)
Introduction: Tumor Treating Fields (TTFields) therapy used concomitantly with maintenance temozolomide through second progression after radio-chemotherapy is associated with improved survival outcomes compared to adjuvant temozolomide alone in indiv
Externí odkaz:
https://doaj.org/article/d4a8fea16aeb4c7aae169565d33a5fb6
Autor:
Marisa Torres Velasco, Rafael Álvarez Gallego, Paloma Peinado, Cesar Muñoz Gregorio, Lisardo Ugidos, Marcial García Morillo, Emilio Vicente, Yolanda Quijano, Susana Prados, Enrique de la Fuente, Antonio Cubillo Gracián
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 843-851 (2024)
Introduction: Hepatocellular carcinoma (HCC) is an aggressive solid tumor associated with high mortality. Surgery is the main treatment consideration for early disease, but patients who present with locally advanced or metastatic HCC at diagnosis hav
Externí odkaz:
https://doaj.org/article/8bc7d2a1de864b599abfa6468aa9ec53
Autor:
Priya Kumthekar, Madison Lyleroehr, Leilani Lacson, Rimas V. Lukas, Karan Dixit, Roger Stupp, Timothy Kruser, Jeff Raizer, Alexander Hou, Sean Sachdev, Margaret Schwartz, Jessica Bajas PA, Ray Lezon, Karyn Schmidt, Christina Amidei, Karen Kaiser
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Tumor Treating Fields (TTFields) Therapy is an FDA-approved therapy in the first line and recurrent setting for glioblastoma. Despite Phase 3 evidence showing improved survival with TTFields, it is not uniformly utilized. We aimed
Externí odkaz:
https://doaj.org/article/d7895edb0e734564b205c572113db00c
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
TTFields is a novel FDA-approved technology utilized for treating glioblastoma multiforme (GBM) within the brain. Presently, the effectiveness of therapy is evaluated through MRI imaging at random two-month intervals. Electrical impedance is an impor
Externí odkaz:
https://doaj.org/article/8738864541d045e89fa304c5f75562de
Autor:
Jia Tian, Julianne C. Mallinger, Ping Shi, Dahao Ling, Loic P. Deleyrolle, Min Lin, Habibeh Khoshbouei, Matthew R. Sarkisian
Publikováno v:
Translational Oncology, Vol 45, Iss , Pp 101956- (2024)
Tumor Treating Fields (TTFields) extend the survival of glioblastoma (GBM) patients by interfering with a broad range of tumor cellular processes. Among these, TTFields disrupt primary cilia stability on GBM cells. Here we asked if concomitant treatm
Externí odkaz:
https://doaj.org/article/57ef9904b530417fbe1d5d0a9438b3c5
Autor:
Yani Berckmans, Hila M. Ene, Kerem Ben-Meir, Antonia Martinez-Conde, Roxanne Wouters, Bieke Van den Ende, Sara Van Mechelen, Roni Monin, Roni Frechtel-Gerzi, Hila Gabay, Eyal Dor-On, Adi Haber, Uri Weinberg, Ignace Vergote, Moshe Giladi, An Coosemans, Yoram Palti
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundOvarian cancer is the leading cause of mortality among gynecological malignancies. Carboplatin and poly (ADP-ribose) polymerase inhibitors (PARPi) are often implemented in the treatment of ovarian cancer. Homologous recombination deficient
Externí odkaz:
https://doaj.org/article/3e0b6e18f9dc4e9395f4d2768ea4274b
Autor:
Li Zhang, Yanming Ren, Youheng Peng, Yong Luo, Yanhui Liu, Xiang Wang, Yuan Yang, Lei Liu, Ping Ai, Xiaoyan Yang, Yanchu Li, Qing Mao, Feng Wang
Publikováno v:
Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)
Abstract Background and Objective High‐grade glioma (HGG) is known to be characterized by a high degree of malignancy and a worse prognosis. The classical treatment is safe resection supplemented by radiotherapy and chemotherapy. Tumor treating fie
Externí odkaz:
https://doaj.org/article/1e0809a7c5ec46bb957344dc8f2d00d9
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Glioma has a high malignant degree and poor prognosis, which seriously affects the prognosis of patients. Traditional treatment methods mainly include craniotomy tumor resection, postoperative radiotherapy and chemotherapy. Although above methods hav
Externí odkaz:
https://doaj.org/article/6ebf486390f042b693be7735565454b4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Radiology and Oncology, Vol 57, Iss 3, Pp 279-291 (2023)
Tumor Treating Fields (TTFields) is a non-invasive modality for cancer treatment that utilizes a specific sinusoidal electric field ranging from 100 kHz to 300 kHz, with an intensity of 1 V/cm to 3 V/cm. Its purpose is to inhibit cancer cell prolifer
Externí odkaz:
https://doaj.org/article/c78f0c8805a94f38a42f5ac782c2076e